Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000227556, named "Pseudogene fragment similar to putative dimethyladenosine transferase," is a noncoding pseudogene. It is defined by sequence similarity to the human gene encoding dimethyladenosine transferase (also known as DIMT1), an RNA methyltransferase involved in ribosome biogenesis and cellular translation[4]. However, unlike its functional counterpart, this entity does not produce an active enzyme, and there is no evidence of it acting as a therapeutic target, biomarker, or being involved in any pathological or normal cellular processes[3][4]. Pseudogenes typically lack protein-coding potential and, unless otherwise proven, are not considered targets for drug discovery or clinical intervention[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene fragment similar to putative dimethyladenosine transferase.